This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For many pharmaceuticalcompanies, with complex, multinational operations, the challenge is devising a net-zero roadmap that is both effective and sustainable. Large energy users such as pharmaceuticalmanufacturers can play an important role in protecting grid stability while enabling more renewable generation.
This initiative was a collaborative effort by AIPAC, the Society for Pharmaceutical Dissolution Science (SPDS), the Indian Drug Manufacturers Association (IDMA-MP), and the Madhya Pradesh State Drugs and PharmaceuticalManufacturers Association (MPSDMA). The programme was led by S.
senators sent letters to five telehealth companies that offer care through direct-to-consumer portals from pharmaceuticalmanufacturers Pfizer and Eli Lilly, interrogating their financial relationships , STAT tells us. Best of luck, and do keep in touch… A group of U.S. Dick Durbin (D-Ill.)
PharmaceuticalManufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceuticalmanufacturing and packaging industry. The Congress gathers pharmaceuticalcompanies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies.
Revolutionising pharma the adaptive way Pharmaceuticalmanufacturing is undergoing a transformative development, driven by innovative technologies that enable right-first time (RFT) production and adaptive scaling to meet changing demands. Why is adaptive manufacturing necessary?
This framework delivers a clear strategy for companies to incorporate digital technologies, enable real-time release for drug manufacturing and address key challenges such as data silos and integrating legacy infrastructure, according to CPI.
Our bioprocess portfolio, including recently launched Planova FG1 and THESYS SCS and ACS Columns, has received strong feedback from customers, the company stated. These technologies are part of the larger effort to support pharmaceuticalmanufacturers with enhanced process efficiency and product safety.
PharmaceuticalManufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. PharmaceuticalManufacturing & Packaging Congress provides a networking platform for decision-makers from the pharmaceutical industry to share cases and brand-new solutions in one place.
Quality Documentation and Manufacturing Expertise CDMOs are experienced in generating high-quality documentation required for regulatory submissions and have extensive expertise in drug development and manufacturing.
Discover the leading patient adherence pharmaceuticalcompanies. Pharmaceutical Technology has listed the top patient adherence pharmaceuticalcompanies based on our intel, insights and decades-long expertise in the sector. Patient adherence.
PharmaceuticalManufacturing & Packaging Congress (PHARMAP 2021) will be held on the 28th – 29th of June, 2021 at the BGS online platform. PharmaceuticalManufacturing & Packaging Congress provides the networking platform for the decision-makers from the pharmaceutical industry.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceuticalmanufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.
Based on the new cost estimates, pharmaceuticalmanufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceuticalcompanies seeking to introduce generic drugs into the Japanese market. Retrieved from [link] Japan PharmaceuticalManufacturers Association.
Between September and October 2024, EY-P and OPPI undertook primary research * consulting top CXOs from leading Indian and global multinational pharmaceuticalcompanies, to understand their perspective on the pivotal growth areas for the Indian pharma industry. There should be transparency in all reporting.
43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for PharmaceuticalManufacturing. According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceuticalcompanies.
This allows pharmaceuticalcompanies to identify compliance trends and support negotiations with certainty. The enhancement is particularly significant for pharmaceuticalmanufacturers managing rebates and compliance across international markets, enabling standardisation and adherence to regulatory reporting standards.
Adoption of QMS within pharma and biopharma is increasing due to strict regulations, frequent changes in the manufacturing process and higher demand to increase production capacity. Some pharmaceuticalcompanies are increasing their R&D spending to increase product numbers.
Pharmaceuticalcompanies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. Cybersecurity Challenges Intellectual Property Theft: Pharmaceuticalcompanies invest heavily in research and development. With over 1.9
Implementation of lightweight and portable spectroscopic instruments has “opened up new avenues” for quality assurance and process monitoring in pharmaceuticalmanufacturing, according to the report. This enables pharmaceuticalcompanies to monitor their manufacturing processes at various stages.
The first industrial-scale pharmaceuticalmanufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. billion.
[pharmaceuticalcompanies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.
The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceuticalcompany filings.
Microbes developing resistance to disinfectants is a major emerging problem in pharmaceuticalmanufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health.
So, how do smaller pharmaceuticalcompanies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness? Any purchasing company would ideally like to integrate their acquisitions into their company seamlessly.
The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceuticalcompany filings.
With an increasing focus on ESG, Pharmaceuticalcompanies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 1,948 in Q1 2023, versus 2,528 in the prior quarter.
The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceuticalcompany filings.
The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceuticalcompany filings.
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceuticalcompanies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR). Other reasons include lower sales demand and high investment costs.
With increasing global competition, including incentives from countries such as Singapore and the US, AstraZenecas move signals potential challenges for the UKs ability to retain large-scale pharmaceutical investments. Industry experts warn that this development could have long-term implications for the UKs life sciences sector.
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceuticalmanufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety.
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceuticalmanufacturing site quality rating system, the Quality management maturity (QMM) programme.
the streamlining of pharma manufacturing in the 21st century. It is not just about bringing new technologies to pharmaceuticalmanufacturing, it’s also about making completely new ‘advanced therapies’ ready for production,” he outlined. “VR is an important element of Education 4.0, which is critical to Pharma 4.0,
This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceuticalcompanies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.
” The first panel at the Now & Next Summit featured prominent figures from top pharmaceuticalcompanies. Additionally, digital technologies are crucial in quality management, supply chain, and product integrity within pharmaceuticalmanufacturing.
He mentions that OPPI member companies follow the stringent OPPI Code of Pharmaceutical Practices 2019 (OPPI Code) which is based on the International Federation of PharmaceuticalManufacturers and Associations (IFPMA) Code.
What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceuticalcompanies, acknowledges concerns about pharmaceuticals in the environment (PiE).
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceuticalcompanies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR). Other reasons include lower sales demand and high investment costs.
The innovative programme is set to strengthen clinical trials and improve medicine manufacturing in the UK. Additionally, further funding from pharmaceuticalcompanies will help to establish the investment programme. Importantly, NHS patients will be able to access new treatments earlier.
Pharmaceutical wholesalers act as intermediaries between pharmaceuticalmanufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs.
His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceuticalcompanies to CROs and academic researchers to patient advocacy organizations.
The event is a joint initiative between AIPAC, Society for Pharmaceutical Dissolution Science (SPDS), Indian Drug Manufacturers Association-MP State Board (IDMA-MP), and Madhya Pradesh State Drugs and PharmaceuticalManufacturers Association (MPSDMA).
Compounding the situation to understand how such an outcome was allowed to occur is the fact that many deals between government and pharmaceuticalcompanies selling the treatments and vaccines were agreed under terms of confidentiality. The discussions over the treaty are set to continue for some time.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content